• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Table 1SIP Submission - Statement Indicating No Relevant Studies Have been Conducted

CompanyProductDescription of SubmissionNumber of Published StudiesNumber of Unpublished StudiesNumber of Clinical Trials
APP PharmaceuticalsHeparin Sodium InjectionLetter stating that no relevant studies had been conducted with this drug000
BayerRefludan (Lepirudin)000
The Medicines CompanyBivalirudin000

From: Appendix F, Scientific Information Packet Tables

Cover of Pharmacologic and Mechanical Prophylaxis of Venous Thromboembolism Among Special Populations
Pharmacologic and Mechanical Prophylaxis of Venous Thromboembolism Among Special Populations [Internet].
Comparative Effectiveness Reviews, No. 116.
Singh S, Haut ER, Brotman DJ, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.